| Impact Factor: 3.476 Editor-in-Chief: Daniel W Chan |
Dear Prof CERASALE MORTEO,
We are very pleased to announce that the open access journal Clinical Proteomics has received its first Impact Factor of 3.476.
We are very pleased to announce that the open access journal Clinical Proteomics has received its first Impact Factor of 3.476.
As you know, the Impact Factor is just one measure used for evaluating a journal. Should you be interested in more information on the Impact Factor in general and alternative metrics, please click here.
Read these influential articles and submit your next manuscript to the journal.
Influential Articles
| REVIEW | ||||
| Nanotechnologies in Glycoproteomics | ||||
 |
| |||
| REVIEW | ||||
| Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges | ||||
 |
| |||
| RESEARCH | ||||
| A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers | ||||
 |
| |||
Journal Scope
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.
The Benefits of Publishing with Us
| • | Rapid, stringent peer-review - most first editorial decisions are made within 40 days |
| • | Provides a unique venue for international reviews and perspectives |
| • | Publishes research across the broad spectrum of clinical and translational proteomics |
Please forward this email and share the good news.
Best wishes,
The BioMed Central Team
The BioMed Central Team
For further information or enquiries please contact Customer Services at:info@biomedcentral.com.
BioMed Central Ltd
236 Gray's Inn Road, London, WC1X 8HB,
United Kingdom.
Editor's profile
Dr Daniel W Chan is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery and Translation at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 300 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr Chan is an active member of US Human Proteome Organization (USHUPO), American Association for Cancer Research (AACR) and American Association for Clinical Chemistry (AACC).
- RESEARCH
Phosphotyrosine profiling of curcumin-induced signaling
Published on: 15 June 2016 - RESEARCH
Synovial fluid proteome in rheumatoid arthritis
Published on: 5 June 2016 - RESEARCH
- REVIEW
Clinical proteomics of enervated neurons
Published on: 5 May 2016 - REVIEW
Challenges and opportunities of bovine milk analysis by mass spectrometry
Published on: 19 April 2016
No hay comentarios:
Publicar un comentario